Filing Details
- Accession Number:
- 0001225208-22-004925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-21 16:38:43
- Reporting Period:
- 2022-03-17
- Accepted Time:
- 2022-03-21 16:38:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1768503 | Thibaut Mongon | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Exec Vp, Ww Chair, Consumer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-17 | 1,420 | $176.28 | 62,394 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 1,657 | $176.28 | 60,737 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 1,735 | $176.28 | 59,002 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 1,757 | $176.28 | 57,245 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 1,856 | $176.28 | 55,389 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 1,976 | $176.28 | 53,413 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 2,944 | $176.28 | 50,469 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 3,770 | $176.16 | 46,699 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-03-17 | 6,566 | $176.24 | 40,133 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |